Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:EVGNNASDAQ:GAMCNASDAQ:NITONASDAQ:SNES On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEVGNEvogene$1.11$1.28$0.95▼$9.00$5.96M1.37176,495 shs68,059 shsGAMCGolden Arrow Merger$6.10-14.4%$1.03$8.37▼$17.02$47.37M0.015,213 shs105,378 shsNITON2OFF$0.25+8.2%$0.32$0.16▼$3.49$4.45M1.86.88 million shs1.97 million shsSNESSenesTech$2.27+4.1%$2.25$1.30▼$9.80$4.03M-0.0379,752 shs34,199 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEVGNEvogene+1.83%+14.43%-19.27%-33.13%-83.42%GAMCGolden Arrow Merger+34.27%+2,869.60%+2,138.62%+2,149.21%-33.67%NITON2OFF+1.81%+5.33%-17.76%-81.06%-78.20%SNESSenesTech+20.44%+11.79%-0.46%-28.76%-71.36%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEVGNEvogene2.6934 of 5 stars3.55.00.00.02.90.00.6GAMCGolden Arrow MergerN/AN/AN/AN/AN/AN/AN/AN/ANITON2OFF1.2204 of 5 stars0.05.00.00.01.91.70.6SNESSenesTech2.0938 of 5 stars3.54.00.00.00.60.01.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEVGNEvogene 3.00Buy$12.00981.08% UpsideGAMCGolden Arrow Merger 0.00N/AN/AN/ANITON2OFF 0.00N/AN/AN/ASNESSenesTech 3.00Buy$10.00340.53% UpsideCurrent Analyst Ratings BreakdownLatest GAMC, EVGN, NITO, and SNES Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/7/2025EVGNEvogeneAlliance Global PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy(Data available from 4/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEVGNEvogene$8.51M0.70N/AN/A$6.96 per share0.16GAMCGolden Arrow MergerN/AN/AN/AN/A($2.53) per shareN/ANITON2OFF$210K21.20N/AN/A$2.19 per share0.11SNESSenesTech$1.86M2.17N/AN/A$12.36 per share0.18Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEVGNEvogene-$23.88M-$3.11N/A∞N/A-314.43%-109.05%-52.55%5/22/2025 (Estimated)GAMCGolden Arrow Merger-$1.47MN/A0.00∞N/AN/AN/A-24.61%N/ANITON2OFF-$6.52MN/A0.00∞N/A-3,165.66%-96.06%-83.65%5/21/2025 (Estimated)SNESSenesTech-$7.71M-$9.97N/AN/AN/A-403.51%-150.33%-125.40%5/8/2025 (Estimated)Latest GAMC, EVGN, NITO, and SNES EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/22/2025Q1 2025EVGNEvogene-$0.5050N/AN/AN/A$4.42 millionN/A3/12/2025Q4 2024SNESSenesTech-$1.50-$1.22+$0.28-$1.22$0.71 million$0.50 million3/6/2025Q4 2024EVGNEvogene-$0.72$0.06+$0.78$0.06$3.63 million$1.61 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEVGNEvogeneN/AN/AN/AN/AN/AGAMCGolden Arrow MergerN/AN/AN/AN/AN/ANITON2OFFN/AN/AN/AN/AN/ASNESSenesTechN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEVGNEvogeneN/A1.091.03GAMCGolden Arrow MergerN/A0.040.04NITON2OFFN/A6.526.42SNESSenesTech0.056.324.92Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEVGNEvogene10.40%GAMCGolden Arrow Merger5.52%NITON2OFF61.24%SNESSenesTech5.19%Insider OwnershipCompanyInsider OwnershipEVGNEvogene7.40%GAMCGolden Arrow Merger77.40%NITON2OFF8.23%SNESSenesTech9.99%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEVGNEvogene1405.37 million4.97 millionOptionableGAMCGolden Arrow Merger17.77 million1.76 millionNot OptionableNITON2OFF217.81 million12.63 millionN/ASNESSenesTech301.78 million931,000Not OptionableGAMC, EVGN, NITO, and SNES HeadlinesRecent News About These CompaniesStockNews.com Initiates Coverage on SenesTech (NASDAQ:SNES)April 19, 2025 | americanbankingnews.comSenesTech's Evolve™ Deployed in Chicago NeighborhoodsApril 17, 2025 | prnewswire.comSenesTech at Lytham Partners: Rodent Control Innovation Drives GrowthApril 3, 2025 | investing.comSenesTech to Participate in the Lytham Partners 2025 Industrials & Basic Materials Investor Summit on April 1, 2025March 31, 2025 | prnewswire.comSenesTech reports Q4 EPS ($1.22) vs. ($48.68) last yearMarch 13, 2025 | markets.businessinsider.comSenesTech announces additional operating optimization initiativesMarch 13, 2025 | markets.businessinsider.comSenesTech Reports Record Revenue Growth and Profit MarginsMarch 13, 2025 | tipranks.comSenesTech, Inc. (SNES) Q4 2024 Earnings Call TranscriptMarch 12, 2025 | seekingalpha.comSenesTech Announces Record Fourth Quarter and Full Year 2024 Financial Results with 70% Quarterly Revenue Growth; Gross Profit Margins of 61%; Reduction in Operating Expenses; and Dramatic Improvement in Adjusted EBITDAMarch 12, 2025 | prnewswire.comSenesTech exercises warrants for $1.1M in gross proceedsMarch 10, 2025 | markets.businessinsider.comSenesTech Announces Warrant Exercise for $1.1 Million in Gross ProceedsMarch 10, 2025 | prnewswire.comSenesTech to Report Fourth Quarter and Fiscal Year 2024 Financial Results on Wednesday, March 12, 2025March 6, 2025 | prnewswire.comSenesTech expands rodent control product into Australia and New Zealand marketsFebruary 25, 2025 | markets.businessinsider.comSenesTech Expands its Rapidly Growing Global Footprint and Clears Major Regulatory Hurdle, Paving the Way for Use in Australia and New ZealandFebruary 25, 2025 | prnewswire.comSenesTech expands into warehousing, distribution sectorFebruary 19, 2025 | markets.businessinsider.comSenesTech Expands into Warehousing and Distribution Sector with Multi-Pallet Initial Shipment of Evolve Rodent Birth Control™February 18, 2025 | prnewswire.comSenesTech's rodent control now on TractorSupply.comFebruary 10, 2025 | msn.comSenesTech’s Evolve Rodent Birth Control line si now available on TractorSupplyFebruary 10, 2025 | markets.businessinsider.comSenesTech Expands E-Commerce Presence with Evolve Rodent Birth Control™ Now Available on TractorSupply.comFebruary 10, 2025 | prnewswire.comSenesTech enters distribution partnership with SMark for Indian marketFebruary 5, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeGAMC, EVGN, NITO, and SNES Company DescriptionsEvogene NASDAQ:EVGN$1.11 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$1.07 -0.04 (-3.60%) As of 05:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.Golden Arrow Merger NASDAQ:GAMCGolden Arrow Merger Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on acquiring companies in the healthcare and healthcare-related infrastructure industries in the United States and other developed countries. The company was incorporated in 2020 and is based in New York, New York. Golden Arrow Merger Corp. is a subsidiary of Golden Arrow Sponsor, LLC.N2OFF NASDAQ:NITO$0.25 +0.02 (+8.18%) Closing price 04:00 PM EasternExtended Trading$0.25 +0.00 (+0.40%) As of 06:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.N2OFF, Inc., an agri-food tech company, engages in the development and sale of eco-friendly green solutions for the food industry to enhance food safety and shelf life of fresh produce. Its products are based on proprietary blend of food acids combined with various oxidizing agent-based sanitizers and low concentrated fungicides for cleaning, sanitizing, and controlling pathogens on fresh produce that are safer for human consumption and extend their shelf life by reducing their decay. The company's products include SavePROTECT or PeroStar, a processing aid for post-harvest application that is added to fruit and vegetable wash water; and SF3HS and SF3H, a post-harvest cleaning and sanitizing solution to control plant and foodborne pathogens. It also offers SpuDefender for controlling post-harvest potato sprouts; and FreshProtect to control spoilage-creating microorganisms on post-harvest citrus fruit. The company was formerly known as Save Foods, Inc. and changed its name to N2OFF, Inc. in March 2024. N2OFF, Inc. was incorporated in 2009 and is headquartered in Hod HaSharon, Israel.SenesTech NASDAQ:SNES$2.23 +0.05 (+2.29%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy 3 Stocks To Watch For When Tariffs Subside 3 Boring Stocks Outperforming the Market This Year Short Sellers Gave Up on These 3 Names Recently Market Anticipation Builds: Joby Stock Climbs Ahead of Earnings Is Intuitive Surgical a Buy After Volatile Reaction to Earnings? Now Is the Time to Buy ServiceNow—The Rebound Is Real Archer Aviation Gets Analyst Target Upgrade: Time to Load Up? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
